Related Experiment Video
Updated: Mar 19, 2026
03:47
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
1.3K
The Tosca Registry: An Ongoing, Observational, Multicenter Registry for Chronic Heart Failure
M Arcopinto1, A Salzano2, F Ferrara3
1IRCSS Policlinico San Donato Milanese, San Donato, Milano.
Translational Medicine @ Unisa
|June 22, 2016
Summary
Population ageing and chronic diseases present healthcare challenges. The TOSCA project investigates hormone interactions in chronic heart failure (CHF) and polypharmacy to improve clinical care and patient outcomes.
Area of Science:
- Gerontology and Public Health
- Cardiology and Endocrinology
- Health Services Research
Background:
- Western populations are ageing, increasing chronic diseases and comorbidity.
- This demographic shift necessitates more effective, sustainable, and cost-efficient healthcare solutions.
- The European Innovation Partnership on Active and Healthy Ageing promotes independent living in older adults.
Purpose of the Study:
- To discuss key concepts relevant to active and healthy ageing.
- To present local research and educational projects, including the TOSCA project.
- To address the challenges of polypharmacy in complex patient management.
Main Methods:
- Review of key concepts related to the European Innovation Partnership on Active and Healthy Ageing.
- Presentation of the multicentre TOSCA (Trattamento Ormonale nello Scompenso CArdiaco) project.
- Discussion of the scientific background and current status of the TOSCA project.
Main Results:
- The TOSCA project focuses on hormone interactions in chronic heart failure (CHF).
- It aims to develop improved clinical care models for patients with CHF.
- The project also addresses the growing challenge of polypharmacy in managing complex patients.
Conclusions:
- Effective management of ageing populations requires innovative healthcare approaches.
- The TOSCA project contributes to understanding CHF, hormone interactions, and polypharmacy.
- Addressing polypharmacy is crucial for economic, organizational, and clinical improvements in patient care.
More Related Videos
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
21.0K
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
3.5K
Related Concept Videos
01:26Heart Failure III: Clinical Manifestations
797
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
797
01:27Heart Failure I: Introduction
1.2K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.2K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
539
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
539
01:29Heart Failure II: Pathophysiology
1.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
01:30Heart Failure V: Medical Management
478
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
478
01:17Pathophysiology of Heart Failure
4.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K